Temozolomide: Difference between revisions
From OncoWiki
Jump to navigationJump to search
m (1 revision) |
(No difference)
|
Latest revision as of 02:18, 7 February 2012
Drug information
Temodar
- Monograph (FDA, PDF)
- Dosage calculator
Indications
Primary CNS Lymphoma
- 150 mg/m2/d po d1-5 q4w
References
Reni M et al. Temozolomide as salvage treatment in primary brain lymphomas. Br J Cancer 2007; 96:864
Anaplastic astrocytoma and glioblastoma
Chemotherapy for recurrent and progressive cancer
- 50-200 mg/m2 po d1-5
Q4w
References
Anaplastic oligodendroglioma
Chemotherapy for recurrent and progressive cancer
- 150-200 mg/m2 po d1-5
Q4w
References
Melanoma
Metastatic cancer
- Temozolomide (Temodar) 200 mg/m2/d po d1-5
Q4w